ArticleEBioMedicine2019

Role of immune checkpoint inhibitor-based therapies for metastatic renal cell carcinoma in the first-line setting: A Bayesian network analysis.

Junpeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.